May 6, 2021

Vigene Biosciences Speaking at the 2021 ASGCT Annu...

April 6, 2021

Vigene Biosciences Speaking at BioProcessing Inter...

March 24, 2021

Vigene Biosciences Speaking at ISBioTech’s S...

March 3, 2021

Vigene Biosciences Speaking at BioProcessing Inter...

February 5, 2021

Maryland Department of Commerce: Vigene Bioscience...

Vigene Biosciences Plans Major Expansion in Montgomery County, Adding up to 245 New Jobs   Global leader in gene therapy […]
January 22, 2021

Vigene Biosciences Speaking at ISBioTech’s N...

November 3, 2020

Vigene Strengthens Management Team with Another Ke...

Vigene Biosciences announces today another key executive addition. Audrey Chang, Ph.D. is appointed as the VP of QC and Analytical Services.
October 12, 2020

Vigene Strengthens Management Team Critical Execut...

Vigene Biosciences announces today an executive addition. Molly McGlaughlin is appointed as Chief Operation Officer.
October 9, 2020

Rznomics Announces Manufacturing Agreement with Vi...

Vigene has entered a contract manufacturing agreement with Rznomics Inc. for its leading pipeline product, RZ-001. RZ-001 is a gene therapy for advanced hepatocellular carcinoma (HCC).
August 31, 2020

Vigene Biosciences made the 2020 Inc. 5000 list of...

Vigene Biosciences made the 2020 Inc. 5000 list of the fastest-growing private companies in America!